229 related articles for article (PubMed ID: 7905955)
1. Risk of endometrial cancer after tamoxifen treatment of breast cancer.
van Leeuwen FE; Benraadt J; Coebergh JW; Kiemeney LA; Gimbrère CH; Otter R; Schouten LJ; Damhuis RA; Bontenbal M; Diepenhorst FW
Lancet; 1994 Feb; 343(8895):448-52. PubMed ID: 7905955
[TBL] [Abstract][Full Text] [Related]
2. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen.
Bergman L; Beelen ML; Gallee MP; Hollema H; Benraadt J; van Leeuwen FE
Lancet; 2000 Sep; 356(9233):881-7. PubMed ID: 11036892
[TBL] [Abstract][Full Text] [Related]
3. Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC).
Mignotte H; Lasset C; Bonadona V; Lesur A; Luporsi E; Rodier JF; Cutuli B; Lasry S; Mauriac L; Granon C; Kerr C; Giard S; Hill C; de Lafontan B; de Gislain C; D'Anjou J; Fondrinier E; Lefeuvre C; Parache RM; Chauvin F
Int J Cancer; 1998 May; 76(3):325-30. PubMed ID: 9579567
[TBL] [Abstract][Full Text] [Related]
4. Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers.
Cook LS; Weiss NS; Schwartz SM; White E; McKnight B; Moore DE; Daling JR
J Natl Cancer Inst; 1995 Sep; 87(18):1359-64. PubMed ID: 7658496
[TBL] [Abstract][Full Text] [Related]
5. Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countries.
Jones ME; van Leeuwen FE; Hoogendoorn WE; Mourits MJ; Hollema H; van Boven H; Press MF; Bernstein L; Swerdlow AJ
Breast Cancer Res; 2012 Jun; 14(3):R91. PubMed ID: 22691381
[TBL] [Abstract][Full Text] [Related]
6. Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer.
Fornander T; Hellström AC; Moberger B
J Natl Cancer Inst; 1993 Nov; 85(22):1850-5. PubMed ID: 8230266
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
Swerdlow AJ; Jones ME;
J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen therapy for breast cancer and endometrial cancer risk.
Bernstein L; Deapen D; Cerhan JR; Schwartz SM; Liff J; McGann-Maloney E; Perlman JA; Ford L
J Natl Cancer Inst; 1999 Oct; 91(19):1654-62. PubMed ID: 10511593
[TBL] [Abstract][Full Text] [Related]
9. Endometrial cancer following breast cancer: Effect of tamoxifen and castration by radiotherapy.
Sasco AJ; Chaplain G; Amoros E; Saez S
Epidemiology; 1996 Jan; 7(1):9-13. PubMed ID: 8664408
[TBL] [Abstract][Full Text] [Related]
10. Outcomes in patients with primary breast cancer and a subsequent diagnosis of endometrial cancer : comparison of cohorts treated with and without tamoxifen.
Saadat M; Truong PT; Kader HA; Speers CH; Berthelet E; McMurtrie E; Olivotto IA
Cancer; 2007 Jul; 110(1):31-7. PubMed ID: 17510927
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic study of 56 patients with endometrial cancer during or after adjuvant tamoxifen use for their breast cancers.
Hachisuga T; Saito T; Kigawa J; Ohwada M; Yamazawa K; Yasue A; Iwasaka T; Sugiyama T; Kita T; Nagai N
Gynecol Oncol; 2004 Oct; 95(1):139-44. PubMed ID: 15385123
[TBL] [Abstract][Full Text] [Related]
12. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.
Fisher B; Costantino JP; Redmond CK; Fisher ER; Wickerham DL; Cronin WM
J Natl Cancer Inst; 1994 Apr; 86(7):527-37. PubMed ID: 8133536
[TBL] [Abstract][Full Text] [Related]
13. The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma.
Katase K; Sugiyama Y; Hasumi K; Yoshimoto M; Kasumi F
Cancer; 1998 May; 82(9):1698-703. PubMed ID: 9576291
[TBL] [Abstract][Full Text] [Related]
14. Risk for endometrial cancer following breast cancer: a prospective study in Sweden.
Adami HO; Bergström R; Weiderpass E; Persson I; Barlow L; McLaughlin JK
Cancer Causes Control; 1997 Nov; 8(6):821-7. PubMed ID: 9427424
[TBL] [Abstract][Full Text] [Related]
15. [Endometrial cancer and tamoxifen. Discussion apropos of a series of cases].
Sasco AJ; Ah-Song R; Gendre I; Zlatoff P; Bobin JY; Hallonet P; Leduc B
Bull Cancer; 1997 Jan; 84(1):51-60. PubMed ID: 9180860
[TBL] [Abstract][Full Text] [Related]
16. Endometrial carcinoma associated with breast carcinoma: low incidence with tamoxifen use.
Cuenca RE; Giachino J; Arredondo MA; Hempling R; Edge SB
Cancer; 1996 May; 77(10):2058-63. PubMed ID: 8640670
[TBL] [Abstract][Full Text] [Related]
17. Surveillance for uterine abnormalities in tamoxifen-treated breast carcinoma survivors: a community based study.
Althuis MD; Sexton M; Langenberg P; Bush TL; Tkaczuk K; Magaziner J; Khoo L
Cancer; 2000 Aug; 89(4):800-10. PubMed ID: 10951343
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen and toremifene treatment of breast cancer and risk of subsequent endometrial cancer: a population-based case-control study.
Pukkala E; Kyyrönen P; Sankila R; Holli K
Int J Cancer; 2002 Jul; 100(3):337-41. PubMed ID: 12115550
[TBL] [Abstract][Full Text] [Related]
19. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
Hauth E; Libera H; Kimmig R; Forsting M
Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
[TBL] [Abstract][Full Text] [Related]
20. Endometrial carcinoma in a tamoxifen-treated breast cancer patient.
Jose R; Kekre AN; George SS; Seshadri L
Aust N Z J Obstet Gynaecol; 1995 May; 35(2):201. PubMed ID: 7677690
[No Abstract] [Full Text] [Related]
[Next] [New Search]
